EligibleTrials

Clinical trials recruiting for G12D Mutated KRAS

Fewer than 3 recruiting trials found.

2
Recruiting trials
17
US states with sites
3
Countries
0%
Accept healthy volunteers

Phase breakdown

Phase 1 1Phase 2 2

Drugs and treatments being studied

InterventionTrials
Cetuximab2
VS-73752
Carboplatin + Pemetrexed + Pembrolizumab1
Gemcitabine1
gemcitabine + nab-paclitaxel1

Where trials are recruiting (top US states)

StateRecruiting trials
California2
Maryland2
Massachusetts2
Michigan2
Missouri2
New York2
Tennessee2
Texas2
Utah2
Virginia2
Washington2
Florida1

Top cities

Ann Arbor, Michigan 2Baltimore, Maryland 2Boston, Massachusetts 2Charlottesville, Virginia 2Fairfax, Virginia 2Houston, Texas 2Los Angeles, California 2Nashville, Tennessee 2New York, New York 2Seattle, Washington 2

Self-screener

Recruiting trials

Related conditions

Trials recruiting for G12D Mutated KRAS often also study these conditions. Each links to its own recruiting-trial list.

Pancreatic cancer 870Solid Tumor, Adult 38Pancreatic Ductal Adenocarcinoma (PDAC) 32Pancreatic Ductal Adenocarcinoma 64Non-small cell lung cancer 507Lung cancer 2180Colorectal cancer 1359

Common questions

Are these trials free to join?

Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.

How do I know if I am eligible for G12D Mutated KRAS trials?

Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.

Is this list complete?

No. For the full list, search ClinicalTrials.gov.

Get notified when new trials open

One email when new recruiting trials are added. Unsubscribe anytime.